Pharma Mar (Spain) Price Prediction
| PHM Stock | EUR 73.50 0.40 0.55% |
Oversold Vs Overbought
81
Oversold | Overbought |
Using Pharma Mar hype-based prediction, you can estimate the value of Pharma Mar SA from the perspective of Pharma Mar response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Pharma Mar to buy its stock at a price that has no basis in reality. In that case, they are not buying Pharma because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Pharma Mar after-hype prediction price | EUR 73.5 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Pharma |
Pharma Mar After-Hype Price Prediction Density Analysis
As far as predicting the price of Pharma Mar at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Pharma Mar or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Pharma Mar, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Pharma Mar Estimiated After-Hype Price Volatility
In the context of predicting Pharma Mar's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Pharma Mar's historical news coverage. Pharma Mar's after-hype downside and upside margins for the prediction period are 68.98 and 78.02, respectively. We have considered Pharma Mar's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Pharma Mar is very steady at this time. Analysis and calculation of next after-hype price of Pharma Mar SA is based on 3 months time horizon.
Pharma Mar Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Pharma Mar is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Pharma Mar backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Pharma Mar, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.98 | 4.48 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Within a week |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
73.50 | 73.50 | 0.00 |
|
Pharma Mar Hype Timeline
Pharma Mar SA is at this time traded for 73.50on Madrid Exchange of Spain. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Pharma is expected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is expected to be very small, whereas the daily expected return is at this time at 0.98%. %. The volatility of related hype on Pharma Mar is about 0.0%, with the expected price after the next announcement by competition of 73.50. About 27.0% of the company outstanding shares are owned by corporate insiders. The company last dividend was issued on the 13th of July 2022. Pharma Mar SA had 1:12 split on the 22nd of July 2020. Assuming the 90 days trading horizon the next expected press release will be within a week. Check out Pharma Mar Basic Forecasting Models to cross-verify your projections.Pharma Mar Related Hype Analysis
Having access to credible news sources related to Pharma Mar's direct competition is more important than ever and may enhance your ability to predict Pharma Mar's future price movements. Getting to know how Pharma Mar's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Pharma Mar may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| SLR | Solaria Energa y | 0.00 | 0 per month | 0.00 | (0.20) | 3.72 | (3.63) | 13.57 | |
| GRF | Grifols SA | 0.00 | 0 per month | 1.80 | 0.01 | 4.05 | (2.66) | 11.42 | |
| IAG | International Consolidated Airlines | 0.00 | 0 per month | 1.04 | 0.23 | 3.38 | (2.33) | 8.94 | |
| CLNX | Cellnex Telecom SA | 0.00 | 0 per month | 0.00 | (0.17) | 2.07 | (2.44) | 6.49 | |
| MEL | Melia Hotels | 0.00 | 0 per month | 0.90 | (0) | 2.14 | (1.38) | 4.98 |
Pharma Mar Additional Predictive Modules
Most predictive techniques to examine Pharma price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Pharma using various technical indicators. When you analyze Pharma charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Pharma Mar Predictive Indicators
The successful prediction of Pharma Mar stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Pharma Mar SA, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Pharma Mar based on analysis of Pharma Mar hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Pharma Mar's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Pharma Mar's related companies.
Story Coverage note for Pharma Mar
The number of cover stories for Pharma Mar depends on current market conditions and Pharma Mar's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Pharma Mar is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Pharma Mar's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Pharma Mar Short Properties
Pharma Mar's future price predictability will typically decrease when Pharma Mar's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Pharma Mar SA often depends not only on the future outlook of the potential Pharma Mar's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Pharma Mar's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 18.1 M | |
| Cash And Short Term Investments | 201.9 M |
Complementary Tools for Pharma Stock analysis
When running Pharma Mar's price analysis, check to measure Pharma Mar's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharma Mar is operating at the current time. Most of Pharma Mar's value examination focuses on studying past and present price action to predict the probability of Pharma Mar's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharma Mar's price. Additionally, you may evaluate how the addition of Pharma Mar to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |